Pulse lineResearch With Heart Logo

Midlife cardiovascular health and 20-year cognitive decline: Atherosclerosis Risk in Communities Study results.

TitleMidlife cardiovascular health and 20-year cognitive decline: Atherosclerosis Risk in Communities Study results.
Publication TypeJournal Article
Year of Publication2018
AuthorsGonzález HM, Tarraf W, Harrison K, B Windham G, Tingle J, Alonso A, Griswold M, Heiss G, Knopman D
Secondary AuthorsMosley TH
JournalAlzheimers Dement
Volume14
Issue5
Pagination579-589
Date Published2018 05
ISSN1552-5279
KeywordsAfrican Continental Ancestry Group, Aging, American Heart Association, Atherosclerosis, Cognitive Dysfunction, European Continental Ancestry Group, Female, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, Time Factors, United States
Abstract

INTRODUCTION: The aim was to examine associations between midlife cardiovascular health (CVH) and 20-year cognitive decline among blacks and whites.

METHODS: Midlife CVH metrics (American Heart Association's Life's Simple 7) were calculated and examined in relation to midlife and 20-year change in cognitive function among 13,270 whites and blacks from the Atherosclerosis Risk in Communities Cohort Study. We used linear mixed models to estimate adjusted associations of midlife CVH with midlife cognitive status and change.

RESULTS: Higher midlife (Life's Simple 7) scores and individual metrics, particularly blood pressure and glucose, were associated with better midlife cognition and reduced 20-year decline. Midlife CVH 20-year neuroprotection was more pronounced among whites than blacks.

DISCUSSION: Better midlife CVH was associated with higher midlife and reduced decline in cognitive function 20 years later. However, the benefits of midlife CVH on cognition were stronger for whites than for blacks. Our findings suggest that improved midlife CVH may promote enduring cognitive health.

DOI10.1016/j.jalz.2017.11.002
Alternate JournalAlzheimers Dement
PubMed ID29268079
PubMed Central IDPMC5938099
Grant ListHHSN268201100012C / HL / NHLBI NIH HHS / United States
U01 HL096812 / HL / NHLBI NIH HHS / United States
HHSN268201100010C / HL / NHLBI NIH HHS / United States
P50 AG005131 / AG / NIA NIH HHS / United States
R01 AG048642 / AG / NIA NIH HHS / United States
HHSN268201100008C / HL / NHLBI NIH HHS / United States
HHSN268201100005G / HL / NHLBI NIH HHS / United States
U01 HL096917 / HL / NHLBI NIH HHS / United States
HHSN268201100008I / HL / NHLBI NIH HHS / United States
HHSN268201100007C / HL / NHLBI NIH HHS / United States
HHSN268201100011I / HL / NHLBI NIH HHS / United States
HHSN268201100011C / HL / NHLBI NIH HHS / United States
U01 HL075572 / HL / NHLBI NIH HHS / United States
U01 HL096902 / HL / NHLBI NIH HHS / United States
RF1 AG054548 / AG / NIA NIH HHS / United States
HHSN268201100006C / HL / NHLBI NIH HHS / United States
HHSN268201100005I / HL / NHLBI NIH HHS / United States
U01 HL096814 / HL / NHLBI NIH HHS / United States
R01 HL070825 / HL / NHLBI NIH HHS / United States
HHSN268201100005C / HL / NHLBI NIH HHS / United States
U01 HL096899 / HL / NHLBI NIH HHS / United States
HHSN268201100007I / HL / NHLBI NIH HHS / United States